Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherArticle

CYP2C19 plays a major role in the hepatic N-oxidation of cotinine

Yadira X Perez-Paramo, Christy J.W. Watson, Gang Chen and Philip Lazarus
Drug Metabolism and Disposition February 23, 2022, DMD-AR-2021-000624; DOI: https://doi.org/10.1124/dmd.121.000624
Yadira X Perez-Paramo
1OMNI-Biomarker Development, Genentech Inc., United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christy J.W. Watson
2Pharmaceutical Sciences, Washington State University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gang Chen
3Pharmaceutical Sciences, WSU College of Pharmacy, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gang Chen
Philip Lazarus
4Pharmaceutical Sciences, Washington State University College of Pharmacy, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: phil.lazarus@wsu.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

DMD-AR-2021-000624
DOI 
https://doi.org/10.1124/dmd.121.000624
PubMed 
35197312

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Published online February 23, 2022.

Article Versions

  • You are currently viewing an Earlier version of this article (February 23, 2022 - 18:05).
  • View the most recent version of this article
Copyright & Usage 
© 2020 The Authors. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited and is not used for commercial purposes.

Author Information

  1. Yadira X Perez-Paramo1,
  2. Christy J.W. Watson2,
  3. Gang Chen3, and
  4. Philip Lazarus4,*
  1. 1OMNI-Biomarker Development, Genentech Inc., United States
  2. 2Pharmaceutical Sciences, Washington State University, United States
  3. 3Pharmaceutical Sciences, WSU College of Pharmacy, United States
  4. 4Pharmaceutical Sciences, Washington State University College of Pharmacy, United States
  1. ↵* Corresponding Author:
    Philip Lazarus, Pharmaceutical Sciences, Washington State University College of Pharmacy, Riverpoint Drive, Spokane, 99212, United States. E-mail: phil.lazarus{at}wsu.edu

Statistics from Altmetric.com

Article usage

Article usage: February 2022 to March 2023

AbstractFullPdf
Feb 20222181190
Mar 2022222696
Apr 2022105035
May 202294032
Jun 2022109031
Jul 202270027
Aug 202290056
Sep 2022144045
Oct 2022124041
Nov 202275028
Dec 20226718873
Jan 202317237114
Feb 20231322452
Mar 2023123638

Next
Back to top

In this issue

Drug Metabolism and Disposition: 51 (4)
Drug Metabolism and Disposition
Vol. 51, Issue 4
1 Apr 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
CYP2C19 plays a major role in the hepatic N-oxidation of cotinine
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherArticle

CYP2C19 variants and cotinine-N-oxide metabolism

Yadira X Perez-Paramo, Christy J.W. Watson, Gang Chen and Philip Lazarus
Drug Metabolism and Disposition February 23, 2022, DMD-AR-2021-000624; DOI: https://doi.org/10.1124/dmd.121.000624

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherArticle

CYP2C19 variants and cotinine-N-oxide metabolism

Yadira X Perez-Paramo, Christy J.W. Watson, Gang Chen and Philip Lazarus
Drug Metabolism and Disposition February 23, 2022, DMD-AR-2021-000624; DOI: https://doi.org/10.1124/dmd.121.000624
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • AKRs and GUSs in Testosterone Disposition
  • Olanzapine Glucuronidation in Humanized Mice
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics